Viewing Study NCT01954251


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-06-17 @ 5:44 PM
Study NCT ID: NCT01954251
Status: COMPLETED
Last Update Posted: 2018-05-02
First Post: 2013-09-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Herpes Zoster View
Keywords:

Keywords

Keyword Brief Keyword Text View
None FLU-D-QIV View
None Adults View
None Safety View
None Immunogenicity View
None co-administration View
None Herpes zoster View